Mesenteric extraskeletal osteosarcoma with telangiectatic features: a case report by Lee, Kyung Hwa et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Cancer
Open Access Case report
Mesenteric extraskeletal osteosarcoma with telangiectatic 
features: a case report
Kyung Hwa Lee1, Jae Kyoon Joo2, Dong Yi Kim2, Ji Shin Lee1, Chan Choi1 
a n d  J a eH y u kL e e * 1
Address: 1Department of Pathology, Chonnam National University Medical School, #8, Hak-dong, Dong-gu, Gwangju, 501-749, Republic of 
Korea and 2Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Medical School, #8, Hak-dong, Dong-
gu, Gwangju, 501-749, Republic of Korea
Email: Kyung Hwa Lee - azimmed@hanmail.net; Jae Kyoon Joo - jkju@chonnam.ac.kr; Dong Yi Kim - dockim@jnu.ac.kr; 
Ji Shin Lee - jshinlee@hanmail.net; Chan Choi - cchoi@chonnam.ac.kr; Jae Hyuk Lee* - jhlee@chonnam.ac.kr
* Corresponding author    
Abstract
Background:  Extraskeletal osteosarcoma is a rare malignant mesenchymal tumor, with a
predominant occurrence in the extremities. Only two cases of mesenteric extraskeletal
osteosarcoma have been documented. We describe an unusual case of extraskeletal osteosarcoma
with telangiectatic features occurring in the mesentery.
Case presentation: A 67-year-old male presented with blood-tinged stool of 1-month's duration.
On colonoscopy, a solid mass was detected protruding from the colon wall. Computed
tomography showed a 15 × 9.7 cm heterogeneously enhancing mass, with mottled calcification and
a cystic portion, occupying the left upper quadrant of the abdominal cavity. Curative resection of
the tumor was performed, and the excised tumor was composed of large multilocular cysts
containing old hematomas and necrotic debris. The histology revealed an osteosarcoma showing
osteoid formation and blood-filled spaces lined with atypical cells. Despite postoperative
chemotherapy, he developed a recurrent peritoneal mass and multiple lung metastases 3 months
postoperatively.
Conclusion: Given the rarity of cases of mesenteric extraskeletal osteosarcoma, its biologic
behavior at this location remains to be determined. However, extraskeletal osteosarcoma with
telangiectatic features is an uncommon entity to be recognized because of the possible fatal
outcome related to the tumors.
Background
Extraskeletal osteosarcoma (EOS) is a rare malignant mes-
enchymal tumor characterized by the production of neo-
plastic osseous tissues, without attachment to bone or the
periosteum [1]. It occurs predominantly in the lower
extremity, upper extremity, and retroperitoneum, and
rarely in the visceral organs [2]. Of the different histologic
variants of EOS, the telangiectatic variant has only a small
number of subtypes, and its pattern is more often men-
tioned as a minor component of other variants [1-3]. To
date, only two cases of extraskeletal osteosarcoma in the
mesentery have been reported [4,5]. Here, we describe a
case of mesenteric osteosarcoma with telangiectatic fea-
tures.
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Case presentation
A 67-year-old male presented with abdominal pain and
blood-tinged stool of 1-month's duration. His past medi-
cal history revealed hypertension well controlled by med-
ication for 8 years and that he had been a smoker for 20
pack years. His family history was noncontributory. Phys-
ical examination revealed a protuberant abdomen with a
huge tender intra-abdominal mass. Laboratory findings
including blood analysis, serum electrolytes, and hepatic
and renal functions were within normal limits, as was the
serum alkaline phosphatase.
On colonoscopy, a solid mass measuring 5 cm was
detected protruding from the colon wall (Figure 1). The
mass was covered with blood clots and necrotic debris.
Colonoscopic biopsy confirmed a sarcoma of an undeter-
mined type. Computed tomography demonstrated a 15 ×
9.7 cm heterogeneously enhancing mass, with mottled
calcification and a cystic portion, occupying the left upper
quadrant of the abdominal cavity (Figure 2). For curative
resection of the tumor, en bloc mass excision with segmen-
tal colon resection and splenectomy was performed. Dur-
ing the operation, the surgeon described the tumor as
being located in the mesentery and involving the stom-
ach, greater omentum, pancreas, and transverse colon.
The resected tumor measured 18.5 × 13 × 9.5 cm. It was
located in the mesentery and perforated the abutting
colon wall. The external surface of the mass was smooth.
The cut surface consisted of a gray-white to tan-yellow
solid area with a gritty sensation and a large multicystic
area (Figure 3). The cystic portion contained clotted blood
with thin septae and was focally necrotic.
Sections taken from the cystic structure showed large
blood-filled spaces separated by thin septae and smaller
cystic spaces within the solid area. The septal walls con-
sisted of numerous large, bizarre rounded to spindled
cells with multilobed hyperchromatic nuclei, and coarse
granular chromatin (Figure 4A). Sections from the firm,
calcified portion revealed a poorly differentiated sarcoma-
tous tumor showing a solid growth pattern with large ana-
plastic cells and spindle cells (Figure 4B). Giant cells with
multiple bizarre nuclei or osteoclast-like giant cells were
scattered throughout the tumor and were associated with
the areas of hemorrhage. The osteoid was laid down in a
fine ramifying lacework, and was partly calcified (Figure
4C). Transition areas between neoplastic osteoid and car-
tilage were noted (Figure 4D). More than 20 mitoses per
ten high-power fields were observed, and these included
highly atypical forms. Necrosis was evident.
For immunohistochemical studies, paraffin-embedded
tissue was stained using the avidin-biotin peroxidase com-
plex method. The neoplastic cells were positive for vimen-
tin, alpha smooth muscle actin, osteonectin, CD99, and
Computed tomography showing a heterogeneously enhanc- ing mass, with mottled calcification and a cystic portion Figure 2
Computed tomography showing a heterogeneously enhanc-
ing mass, with mottled calcification and a cystic portion.
Colonoscopic findings showing a necrotic mass protruding  from the colon wall Figure 1
Colonoscopic findings showing a necrotic mass protruding 
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S100 in the chondroblastic portion, but negative for
cytokeratin, epithelial membrane antigen, desmin, myo-
genin, CD34, and c-kit. The final histologic diagnosis was
a mesenteric extraskeletal osteosarcoma with telangiec-
tatic features.
After the uneventful surgery, the patient underwent the
first cycle of chemotherapy consisting of intravenous ifos-
famide (1800 mg/m2) and adriamycin (25 mg/m2). How-
ever, he developed a recurrent peritoneal mass measuring
11 × 9.5 cm and multiple lung and liver metastases 3
months postoperatively. He died 4 months later.
Conclusion
Extraskeletal osteosarcoma is a rare soft tissue tumor,
which is reported to account for approximately 1% of all
soft tissue sarcomas and 4% of all osteosarcomas [6,7].
EOS occurs in a patient population distinct from osteosa-
rcoma of bone; EOS most commonly affects individuals
older than 30 years and is rarely encountered during the
first two decades of life [3,6]. The lower extremity is the
most common anatomic site, followed by the upper limb
and retroperitoneum [3].
The English literature includes case reports of EOS arising
in unusual sites, such as the larynx, kidney, esophagus,
small intestine, liver, heart, urinary bladder, parotid, and
breast [3]. Osteosarcoma of the mesentery is extremely
rare, and only two documented cases exist in the litera-
ture. The first case written in German was mentioned
briefly in Fine and Stout's review article [5]. That tumor
was adherent to the peritoneum and bowel with metas-
tases in mesenteric lymph nodes; the patient, a 39-year-
old male, died 55 days postoperatively. Choudur
described the second case, a 15-cm tumor in the pelvic
cavity of a 45-year-old male without any involvement of
the bowel, prostate, or urinary bladder [4]. In our case, the
tumor was so large that it was difficult to determine its ori-
gin. However, both the preoperative image studies and
the intraoperative observation indicated the superficial
involvement of multiple intra-abdominal organs and sug-
gested that the tumor centered on the mesentery. These
findings strongly suggested that our EOS originated in the
mesentery.
Although solid areas in our case showed features of con-
ventional osteosarcoma, the large cystic areas closely
resembled telangiectatic EOS. According to Bane et al., if
the major histologic pattern comprises 75% or more of
the tumor, that pattern is considered predominant [3].
Other authors suggested that telangiectatic osteosarcomas
(TOSs) should be defined as hemorrhagic, cystic, or
necrotic spaces that occupy more than 90% of the lesion
[8,9]. Although the large cystic areas in our case accounted
for more than 75% of the tumor, they did not amount to
90%. Therefore, the histological diagnosis in our case was
extraskeletal osteosarcoma with telangiectatic features.
However, current World Health Organization (WHO)
classification doesn't present any practical guide on the
proportion of cystic portion in diagnosing telangiectatic
osteosarcoma [10].
The criteria for the diagnosis of primary extraskeletal oste-
osarcoma by Allan et al. are as follows: the presence of a
uniform morphological pattern of sarcomatous tissue that
A. Telangiectatic foci with several septae composed of large,  bizarre cells (×100, H&E) Figure 4
A. Telangiectatic foci with several septae composed of large, 
bizarre cells (×100, H&E). B. Poorly differentiated sarcoma-
tous tumor composed of large anaplastic cells (×200, H&E). 
C. Spicules of osteoid and bone between malignant cells 




The cut tumor surface composed of a gritty solid area and a  collapsed cystic portion containing blood clots Figure 3
The cut tumor surface composed of a gritty solid area and a 
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excludes the possibility of malignant mesenchymoma, the
production of malignant osteoid or bone by the sarcoma-
tous tissue, and the ready exclusion of an osseous origin
[6]. The second criterion of Allan et al. is controversial,
especially in the telangiectatic variant of osteosarcomas.
In an article on telangiectatic osteosarcoma of bone, oste-
oid was not found in five of 25 cases (25%) [8]. The first
detailed report on three cases of telangiectatic EOS also
noted the absence of osteoid in one case [1]. Before those
reports on the telangiectatic subtype, the diagnosis of
osteosarcoma was strictly defined as a mesenchymal
tumor characterized by the direct production of osteoid or
bone by malignant cells. With the exception of the tel-
angiectatic variant of osteosarcoma, most authors do not
advocate the diagnosis of osseous or extraosseous osteosa-
rcoma without the appropriate osteoid production [1,11].
A diligent search for osteoid is very important for the diag-
nosis of extraosseous osteosarcoma. In our case, the lim-
ited amount of tumor tissue in the colonoscopic biopsy
concealed the presence of osteoid, so that we were unable
to reach a definite diagnosis. In addition, the seemingly
contradictory results of the immunohistochemistry were
not helpful. Both osseous and extraosseous osteosarco-
mas show notoriously varied immunophenotypes by
reacting to such reagents as factor-XIII related antigen,
S100, desmin, alpha-smooth muscle actin, cytokeratin,
and epithelial membrane antigen [12,13].
The differential diagnosis includes various benign and
malignant soft tissue osteogenic lesions. Previous reports
have indicated that many EOS or telangiectatic EOS cases
were initially misinterpreted as different entities. Occa-
sionally, EOS has been mistaken for myositis ossificans,
which is a benign ossifying process usually occurring in
young adults as a solitary, well circumscribed mass within
skeletal muscle. The typical lesion of myositis ossificans
shows a zoning effect with peripheral differentiation into
well formed bone and a lack of cytologic atypia [3].
Tumor osteoid and bone tend to show "reverse" zonation
characterized by localization toward the center of the
tumor in contrast to that of myositis ossificans. As
mesenteric tumors, intraabdominal myositis ossificans, or
heterotopic mesenteric ossification (HMO) may show
worrisome histologic features, including high cellularity,
frequent mitotic figures, cartilage formation, and woven
bone production. A distinctly zonated growth pattern
without hyperchromatism and bizarre nuclear forms of
HMO will be likewise helpful [14]. Other benign proc-
esses include giant cell tumor of the soft tissues, heman-
gioendothelioma, and even blood clots [8]. The lack of
anaplasia and rarity of septal formation in the first two
should help in the differential diagnosis. Adequate sam-
pling may keep us from making an erroneous diagnosis,
such as blood clot, by identifying other tumor compo-
nents.
The diagnosis of malignant mesenchymoma can be made
by showing two or more identifiable malignant elements,
exclusive of fibrosarcoma, and chondrosarcoma even
when osteogenic sarcoma is identified [3,10]. Among
those with a fatty component are dedifferentiated liposar-
comas with osseous or cartilaginous elements. A thorough
histological review in sufficient sections is needed, as with
carcinomatous components in carcinosarcoma. Another
differential entity that may be encountered is a pleomor-
phic malignant fibrous histiocytoma (MFH), which is
regarded as synonymous with undifferentiated pleomor-
phic sarcoma in the current WHO classification [15].
Some authors insist that a close relationship exists
between EOS and MFH both microscopically and clini-
cally [2,3]. It has been suggested that if the tumor cells are
producing unequivocal osteoid or bone, irrespective of
the amount or location, the tumor should be classified as
an osteosarcoma, while if the osteoid is doubtful, it
should be diagnosed as a pleomorphic MFH or undiffer-
entiated sarcoma [11].
Patients with extraskeletal osteosarcoma generally have a
poor prognosis and the majority develops metastatic dis-
ease within 3 years of diagnosis [16]. The reported overall
mortality rates due to the tumor in the larger series exceed
60% [2,6,7]. Tumor size less than 5 cm seems to be an
important prognostic factor for EOSs [3]. In other series,
however, small size did not equate with a good prognosis
or long-term survival [16]. Given the rarity of cases of tel-
angiectatic EOS or EOS with telangiectatic features in the
literature, we agree with previous publications that more
information needs to be obtained concerning the clinical
outcome for appropriate management, planning, and
prognostic estimation [1].
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KHL performed the review of the literature and partici-
pated in the draft of the manuscript.
JKJ and DYK performed the surgery and provided clinical
information of the patient.
CC participated in the histopathological analysis, and in
the coordination of the study.
JSL participated in the draft of the study, and in the con-
ception of the study.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2007, 7:82 http://www.biomedcentral.com/1471-2407/7/82
Page 5 of 5
(page number not for citation purposes)
JHL conceived the study, was the coordinator of the study,
and drafted the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
Written consent was obtained from the patient for publication of the study.
References
1. Mirra JM, Fain JS, Ward WG, Eckardt JJ, Eilber F, Rosen G: Extraskel-
etal telangiectatic osteosarcoma.  Cancer 1993, 71:3014-3019.
2. Chung EB, Enzinger FM: Extraskeletal osteosarcoma.  Cancer
1987, 60:1132-1142.
3. Bane BL, Evans HL, Ro JY, Carrasco CH, Grignon DJ, Benjamin RS,
Ayala AG: Extraskeletal osteosarcoma. A clinicopathologic
review of 26 cases.  Cancer 1990, 65:2762-2770.
4. Choudur HN, Munk PL, Nielson TO, Ryan AG: Primary
mesenteric extraskeletal osteosarcoma in the pelvic cavity.
Skeletal Radiol 2005, 34:649-652.
5. Fine G, Stout AP: Osteogenic sarcoma of the extraskeletal soft
tissues.  Cancer 1956, 9:1027-1043.
6. Allan CJ, Soule EH: Osteogenic sarcoma of the somatic soft tis-
sues. Clinicopathologic study of 26 cases and review of liter-
ature.  Cancer 1971, 27:1121-1133.
7. Sordillo PP, Hajdu SI, Magill GB, Golbey RB: Extraosseous osteo-
genic sarcoma. A review of 48 patients.  Cancer 1983,
51:727-734.
8. Matsuno T, Unni KK, McLeod RA, Dahlin DC: Telangiectatic oste-
ogenic sarcoma.  Cancer 1976, 38:2538-2547.
9. Murphey MD, Robbin MR, McRae GA, Flemming DJ, Temple HT,
Kransdorf MJ: The many faces of osteosarcoma.  Radiographics
1997, 17:1205-1231.
10. Fletcher CD, Unni KK, Mertens F: Pathology and genetics of
tumours of soft tissue and bone.  Lyon: IARC press; 2002. 
11. Kempso RLFC, Evans HL, Hendrickson MR, Sibley RK: Cartilagi-
nous and osseous tumors.  In Tumors of the soft tissues Volume 30.
3rd edition. Edited by: Rosai JSL. Washington, D.C.: Armed forces
institute of pathology; 2001:395-418. 
12. Hasegawa T, Hirose T, Kudo E, Hizawa K, Usui M, Ishii S: Immu-
nophenotypic heterogeneity in osteosarcomas.  Human Pathol
1991, 22:583-590.
13. Lidang Jensen M, Schumacher B, Myhre Jensen O, Steen Nielsen O,
Keller J: Extraskeletal osteosarcomas: a clinicopathologic
study of 25 cases.  Am J Surg Pathol 1998, 22:588-594.
14. Patel RM, Weiss SW, Folpe AL: Heterotopic mesenteric ossifica-
tion: a distinctive pseudosarcoma commonly associated with
intestinal obstruction.  Am J Surg Pathol 2006, 30:119-122.
15. Fletcher CD: The evolving classification of soft tissue tumours:
an update based on the new WHO classification.  Histopathol-
ogy 2006, 48:3-12.
16. Lee JS, Fetsch JF, Wasdhal DA, Lee BP, Pritchard DJ, Nascimento AG:
A review of 40 patients with extraskeletal osteosarcoma.
Cancer 1995, 76:2253-2259.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/7/82/prepub